UK pharma major GSK (LSE: GSK) yesterday announced that the US Food and Drug Administration (FDA) has approved Nucala ...

Swiss pharma major Roche (ROG: SIX) has reported updated results from its Phase III STARGLO trial, showing that a ...

The oncology community’s biggest gathering returns to Chicago from May 30 to June 3, and all signs suggest the 2025 ASCO ...

The US Food and Drug Administration (FDA) has approved Roche’s (ROG: SIX) Susvimo (ranibizumab injection) 100mg/mL for the ...

South Korean Samsung Group’s biopharmaceutical business is being reorganized into two separate tracks: contract development ...

Chinese drugmaker Jiangsu Hengrui Pharmaceuticals priced its Hong Kong stock offering at the top of the marketed range to ...

USA-based nonprofit CureDuchenne has announced the appointment of Brenda Wong as its new chief medical advisor (CMA), ...

Precision oncology start-up Fore Biotherapeutics, founded in 2011, today announced a $38 million Series D-2 financing.

The US Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective ...

USA-based UroGen Pharma, a biotech developing and commercializing innovative solutions that treat urothelial and specialty ...

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) saw its share price skyrocket more than 240% to $7.89 pre-market, on the news that French pharma major Sanofi (Euronext: SAN) had made a ...

UK pharma major AstraZeneca (LSE: AZN) is set to present data from more than 80 studies at the 2025 American Society of ...